Crossmark

Disruption of lipid-raft localized Gαs/tubulin complexes by antidepressants: a unique feature of HDAC6 inhibitors, SSRI and tricyclic compounds

Crossref DOI link: https://doi.org/10.1038/s41386-018-0016-x

Published Online: 2018-02-05

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Singh, Harinder

Wray, Nathan

Schappi, Jeffrey M.

Rasenick, Mark M.
License Information

Text and Data Mining valid from 2018-02-05
More Information

Article History

Received: 18 October 2017

Revised: 11 January 2018

Accepted: 18 January 2018

First Online: 5 February 2018

Change Date: 7 January 2019

Change Type: Correction

Change Details: The originally published version of this article contained an error in Fig. 1e (imipramine), which was a duplicate of Fig. 1a control. The correct figure appears in the correction article. This error did not affect numeric results, as quantitation shown in the paper was carried out with three correct blots, including the one shown below.

Conflict of interest

: M.M.R. has received research support from Eli Lilly and Lundbeck, Inc. and is consultant to Otsuka Pharmaceuticals. He also has ownership in Pax Neuroscience. The remaining authors have nothing to disclose. H.S., N.W. and J.S. declare no conflicts of interest.